Opus Genetics IRD
NASDAQ IRD
$4.95 -0.10 (-1.88%)
At close: Sep 29, 2026 · 4:00 PM EDT

Opus Genetics (IRD) Total Debt (2019 - 2026)

Updated

Opus Genetics' Total Debt came in at $34.93 million for Q2 2026, compared with $1 million a year earlier.

Analysis

Opus Genetics (IRD) Total Debt (2019 - 2026) Analysis & Trends

At the end of FY2025, Opus Genetics' Total Debt was $1.13 million.

  • Total Debt carries a four-year compound annual growth rate of 20.4% (FY2021 to FY2025).
  • Going back by year, Total Debt was $538,000 in FY2021.
  • The Q2 2026 figure represents the highest quarterly Total Debt in data going back to Q4 2019.
  • Business Quant data shows IRD's Total Debt at $1.2 million (Q1 2026), $1.13 million (Q4 2025) and $1.07 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 49.04 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 70.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -111.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 26.25 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Opus Genetics 417.37 Mn 192.65 Mn - 34.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.93 Mn
Mar 31, 2026 1.20 Mn
Dec 31, 2025 1.13 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 1.00 Mn
Mar 31, 2022 215,000.00
Dec 31, 2021 538,000.00
Dec 31, 2019 4.98 Mn
API Access

Opus Genetics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=IRD&period=max&api_key=YOUR_API_KEY